By using this site, you are consenting to our use of cookies. To find out more visit our privacy policy.
Includes articles, courses, and CPGs. Unlimited access for APTA members.
Jun 12, 2013/Test & Measure
Measures walking speed in meters per second (m/s) over a short duration.
May 31, 2017/Test & Measure
Measures, in supine, the ability to lift the head and neck against gravity for an extended period.
Aug 30, 2017/Test & Measure
Measures the posterior-to-anterior mobility of the spinal segment with/without pain provocation.
Jun 29, 2023/CPG
The purpose of these clinical practice guidelines is to describe the peer-reviewed literature and make recommendations related to nonarthritic hip joint pain.
May 23, 2017/Test & Measure
Patients self rate the presence and severity of signs and symptoms such as blurred vision, dizziness, drowsiness, sleeping more than usual, easily distracted, fatigue, feeling “in a fog,” headache, and irritability.
Risk Assessment Prediction Tool (RAPT)
Jun 28, 2017/Test & Measure
Used during systems review to identify cognitive impairment in various patient populations.
Jun 5, 2017/Test & Measure
This is a 16-item questionnaire, which includes 13 postconcussive syndrome symptoms (PCS) and 3 daily life problems.
Feb 1, 2022/CPG
This guideline provides recommendations related to the management of patients with low back pain. The CPG+ is based on the 2019 version of the guideline.
Jun 22, 2023/Live Webinar
Inside intel from APTA's Health Policy and Payment team on the most significant and impactful federal and commercial payer policy updates in 2023.
